The manufacture of drugs takes place across one of the most complex, multi-channel supply chains in modern industry. So much can go wrong among numerous partners and at myriad junctures. That’s why drug developers and manufacturers should get answers to 10 key questions when considering any third-party partner in the drug manufacturing process. It’s critical to safety, whether for active pharmaceutical ingredients (APIs) or consumption-ready medicines. This article from Thomson Reuters explains.